Comparing how exercise affects blood sugar in adults with and without Type 1 diabetes.
Official title: Inter- and Intraindividual Variability of the Acute Glucose Response to Exercise in Healthy Adults and People Living With Type 1 Diabetes: A Cross-over Replicate Trial
Run by University College Dublin · NCT07209930 · Data updated 2026-11-12
We will see if a standardized bout of cycling causes similar blood sugar changes within the same person and between people, in adults with Type 1 diabetes and in healthy adults, using continuous glucose monitors and finger‑stick checks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | University College Dublin Academic / other |
| Locations | 1 site (Dublin, Dublin) |
| Status | Recruiting |
| Started | January 28, 2025 |
| Main results expected | December 31, 2025 |
| Study ends | July 31, 2026 |
| Registry record updated | October 7, 2025 |
| Trial ID | NCT07209930 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–60 who either have Type 1 diabetes for more than 18 months with intact hypoglycaemia self‑awareness and ability to self‑manage their diabetes, or are healthy adults without diabetes who engage in physical activity at least once weekly, are suitable candidates.
✕Probably not a fit
People with cardiovascular disease or other contraindications to exercise, pregnancy, chronic renal or liver disease, diagnosed eating disorders, active infection, or those unable to safely self‑manage diabetes (including loss of hypoglycaemia awareness) are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized replicate crossover trial with two parallel phases: one for adults with Type 1 diabetes and one for healthy adults, each recruiting about 12 participants. After baseline testing (including body composition and VO2max), participants complete two test conditions (exercise on a cycle ergometer and rest) in randomized order and then repeat the same order the following week to measure reproducibility. Glucose is tracked continuously by CGM and intermittently by capillary blood sampling after a standardized breakfast, with at least 72 hours between test visits. The design compares within‑person repeatability and between‑person variability and also evaluates agreement between CGM and finger‑stick glucose values.
Why it matters
Potential benefit: If successful, the results could help predict individual glucose responses to exercise and improve personalized guidance for safe physical activity in people with Type 1 diabetes.
How similar studies have gone: Prior research has documented substantial variability in glucose responses to exercise and mixed agreement between CGM and capillary blood, so this work builds on existing but unresolved evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: (Healthy and T1D phases): * age between 18 and 60 years old; * being healthy individuals; * engagement in physical activity at least once a week; (T1D phase): * diagnosis of T1D for \>18 months; * hypoglycaemia self awareness. Exclusion Criteria: (Healthy and T1D phases) * presence of cardiovascular disease or contraindications to exercise; * infectious or inflammatory conditions; * chronic renal or liver disease; * pregnancy; * gestational diabetes; * diagnosed eating disorders; * any physical or mental condition preventing participation; (Healthy phase) * diabetes mellitus (type 1 or type 2); (T1D phase) * inability to self-manage diabetes.
Where it's running
-
University College Dublin
Dublin, Dublin, Ireland Recruiting
Study contacts
- Study coordinator: Veronica Merlo
- Email: veronica.merlo@ucdconnect.ie
- Phone: 3458479939
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Intermittent CGM Use in high-risk children and teens with Type 1 Diabetes in the Dominican Republic
This study tests whether using the Dexcom G7 intermittently, along with pediatric care and support, can improve glucose control in 10–19 year-olds with high-risk Type 1 Diabetes in the Dominican Republic.
-
AI-assisted remote insulin pump optimization for people with type 1 diabetes
This study tests an AI-powered tool that suggests insulin pump settings for people with type 1 diabetes, with doctor-approved recommendations delivered to a mobile app.
-
AMX0035 in adults with Type 1 Diabetes
This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.
-
Dietary changes to help adults with Type 1 diabetes and overweight see if moderate carbs, time-restricted eating, or regular calories work
We’re testing three weight-loss approaches in adults with type 1 diabetes who are overweight or obese to see which helps reduce weight safely.
-
Islet re-transplantation after prior graft failure in adults with type 1 diabetes
This study looks at whether giving another islet transplant after a prior failed graft helps adults with type 1 diabetes who have severe swings in blood sugar.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.